S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

RIGL Rigel Pharmaceuticals Inc

20.52

0.82 (4.16%)

08 Mar 2025 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Rigel Pharmaceuticals (NASDAQ:RIGL)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Rigel Pharmaceuticals Charts.

Rigel Pharmaceuticals (NASDAQ:RIGL)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Rigel Pharmaceuticals Charts.

Rigel Pharmaceuticals Inc News

Form 8-K - Current report
Wednesday 5 March 2025 (5 days ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 5 March 2025 (5 days ago) • Edgar (US Regulatory)

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Wednesday 5 March 2025 (5 days ago) • PR Newswire (US)

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update
Wednesday 26 February 2025 (2 weeks ago) • PR Newswire (US)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 15 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

More Rigel Pharmaceuticals Inc News Articles

Jpel Private Equity

Kumiai Chemical Industry (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions